Atlas Trials

Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension

Clinical trial NCT00323297 · COMPLETED

Trial details

NCT number
NCT00323297
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Pulmonary Arterial Hypertension
Start date
2006-09-01
Primary completion
2013-08-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.